Regulation2 min read

New Bipartisan Bill Targets Cannabis Banking Barriers

CLIMB Act would open lending and investment access for state-legal operators, addressing industry's biggest operational hurdle

March 25, 2026 at 2:26 PMCannabismarketcap

The bipartisan Capital Lending and Investment for Marijuana Businesses (CLIMB) Act represents the latest congressional attempt to resolve cannabis banking restrictions that have plagued the industry since state legalization began. Representatives Troy Carter (D-LA) and Guy Reschenthaler (R-PA) introduced legislation targeting the fundamental disconnect between state-legal operations and federal banking regulations that continues to force cannabis companies into cash-heavy business models.

The banking crisis affects every aspect of cannabis operations, from payroll processing to expansion financing. Multi-state operators like Curaleaf (CURLF), Trulieve (TCNNF), and Green Thumb Industries (GTBIF) have built complex financial structures involving credit facilities and private lending arrangements that carry significantly higher costs than traditional banking relationships. These elevated capital costs directly impact margins and limit growth potential across the sector.

While the CLIMB Act joins existing efforts like the SAFE Banking Act, the fragmented approach to cannabis banking reform reflects broader congressional challenges around comprehensive marijuana policy. The SAFE Banking Act has passed the House multiple times but stalled in the Senate, where lawmakers prefer broader reform packages that include social equity provisions and criminal justice reforms. This piecemeal legislative strategy may actually slow progress on banking access.

The timing coincides with increasing pressure on cannabis companies to achieve profitability amid tightening capital markets. Limited banking access forces operators to maintain higher cash reserves and rely on expensive private credit markets, creating competitive disadvantages against traditional retail and consumer goods companies. For institutional investors evaluating cannabis exposure, banking uncertainty remains a primary risk factor affecting sector valuations.

Cannabis banking legislation faces the same political dynamics that have stalled broader reform efforts. While individual bills generate headlines and maintain political momentum, the lack of comprehensive federal framework continues to create operational inefficiencies that directly impact public company performance and investor confidence in the sector.